Impact BioMedical Inc. Announces the Closing of its Initial Public Offering

Stock Information for Impact BioMedical Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Impact BioMedical Inc.

Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates
Impact BioMedical Inc. (NYSE: IBO) Announces 3F(TM) US Patent Issue
Impact BioMedical Inc. Introduces Leadership Team to Drive Innovation and Growth
DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value
Impact BioMedical Inc. Announces Pricing of Initial Public Offering
Universal Ibogaine to Issue Common Shares Pursuant to Debt Settlement
Universal Ibogaine announces closing of private placement financing
Universal Ibogaine provides update on planned Clinical Trial Application process

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.